Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
LeukemiaLymphomaBlood DisordersSolid Tumors
Interventions
DRUG

Ethanol lock therapy (ELT)

Participants will be randomized to receive early (preemptive) ELT (after 12 hours from time blood culture drawn, but before blood culture positive, R/O sepsis) with systemic antimicrobials versus standard ELT (placed in catheter when blood culture is positive for growth of a germ) with systemic antimicrobials.

Trial Locations (1)

48201

Children's Hospital of Michigan, Detroit

All Listed Sponsors
collaborator

Blue Cross Blue Shield of Michigan Foundation

OTHER

lead

Children's Hospital of Michigan

OTHER

NCT02095951 - Preemptive Ethanol Lock Therapy in Pediatric Bloodstream Infection | Biotech Hunter | Biotech Hunter